Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 24, 2026European Heart Journal - Quality of Care and Clinical OutcomesOpen Access

TTN truncating variants linked to ~10-fold higher DCM risk in young AF patients.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

What is the role of cardiomyopathy gene variants in driving early-onset atrial fibrillation and associated clinical outcomes?

Population

Patients with early-onset atrial fibrillation

Design

Review

Key result

Pathogenic variants in cardiomyopathy genes are found in 5-20% of young AF patients, with TTN truncating variants conferring up to a twofold increased risk of AF and tenfold higher risk of DCM.

Authors

JRJohannes ReinholdPCParis ChrysostomouPHPatrick M. Heck

Discussion

Loading...

Member takes

Overview

May support genetic evaluation in young AF; leaves open whether testing improves outcomes or guides therapy.

Key Points

  • This review aims to explore the relationship between cardiomyopathy gene variants and early-onset atrial fibrillation. It highlights the need for genetic testing in at-risk individuals.
  • Synthesis of contemporary evidence from multiple sequencing cohorts
  • Focus on pathogenic variants in TTN, LMNA, MYH7, and PKP2
  • Review of longitudinal studies assessing risks associated with genotype-positive atrial fibrillation
  • Pathogenic variants identified in 5-20% of young atrial fibrillation patients
  • TTN truncating variants increase AF risk by twofold and dilated cardiomyopathy risk by tenfold
  • Genotype-positive AF patients are at higher risk for heart failure and sudden cardiac death

Structured PICO

What is the role of cardiomyopathy gene variants in driving early-onset atrial fibrillation and associated clinical outcomes?

P
Population
Patients with early-onset atrial fibrillation (often before 65 years of age in the absence of structural heart disease)
E
Exposure
Presence of cardiomyopathy-associated gene variants (e.g., TTN, LMNA, MYH7, PKP2) and genetic testing
O
Outcome
Prevalence of pathogenic gene variants and associated risks of heart failure, sudden cardiac death, and progression to overt cardiomyopathy

Early-onset atrial fibrillation may serve as a sentinel manifestation of inherited cardiomyopathy, suggesting that genetic testing in young AF patients could enable early detection and personalized management.

Cite This Study

Reinhold et al. (2026) conducted a review in Early-onset Atrial Fibrillation. Cardiomyopathy gene variants was evaluated. Pathogenic variants in cardiomyopathy genes are found in 5-20% of young AF patients, with TTN truncating variants conferring up to a twofold increased risk of AF and tenfold higher risk of DCM.

synapsesocial.com/papers/6a630179395161722cd16153https://doi.org/10.1093/ehjqcco/qcag113
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Review of Cardiomyopathy Gene Variants as Drivers of Early-Onset Atrial Fibrillation: Linking Genotype to Phenotype in Precision Medicine2026
  2. 2Early onset atrial fibrillation as a marker of inherited cardiomyopathy: lessons from combined imaging and genetic assessment2026
  3. 3Genetic evaluation of early-onset atrial fibrillation: impact on patient management2025
  4. 4Age-Dependent Contributions of Rare and Common Genetic Variation in Atrial Fibrillation2025 · 2 citations
  5. 5Beyond Tachycardia-Induced Cardiomyopathy2025